A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia

NCT01345214 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to slow accrual of subjects.

Conditions

Chemotherapy-Induced Thrombocytopenia

Interventions

DRUG: ONO-7746

Sponsor

Ono Pharma USA Inc